The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: systematic review and radiomics quality score assessment.
Human papillomavirus
Machine learning
Oropharyngeal neoplasms
Radiomics
Systematic review
Journal
Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
08
12
2021
accepted:
07
04
2022
pubmed:
24
4
2022
medline:
14
7
2022
entrez:
23
4
2022
Statut:
ppublish
Résumé
Human papillomavirus (HPV) status assessment is crucial for decision making in oropharyngeal cancer patients. In last years, several articles have been published investigating the possible role of radiomics in distinguishing HPV-positive from HPV-negative neoplasms. Aim of this review was to perform a systematic quality assessment of radiomic studies published on this topic. Radiomics studies on HPV status prediction in oropharyngeal cancer patients were selected. The Radiomic Quality Score (RQS) was assessed by three readers to evaluate their methodological quality. In addition, possible correlations between RQS% and journal type, year of publication, impact factor, and journal rank were investigated. After the literature search, 19 articles were selected whose RQS median was 33% (range 0-42%). Overall, 16/19 studies included a well-documented imaging protocol, 13/19 demonstrated phenotypic differences, and all were compared with the current gold standard. No study included a public protocol, phantom study, or imaging at multiple time points. More than half (13/19) included feature selection and only 2 were comprehensive of non-radiomic features. Mean RQS was significantly higher in clinical journals. Radiomics has been proposed for oropharyngeal cancer HPV status assessment, with promising results. However, these are supported by low methodological quality investigations. Further studies with higher methodological quality, appropriate standardization, and greater attention to validation are necessary prior to clinical adoption.
Identifiants
pubmed: 35459957
doi: 10.1007/s00234-022-02959-0
pii: 10.1007/s00234-022-02959-0
pmc: PMC9271107
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1639-1647Informations de copyright
© 2022. The Author(s).
Références
Sovrem Tekhnologii Med. 2021;13(2):97-104
pubmed: 34513082
Clin Cancer Res. 2009 Feb 1;15(3):986-94
pubmed: 19188170
Dent Clin North Am. 2018 Jan;62(1):111-120
pubmed: 29126488
Radiol Artif Intell. 2020 Mar 25;2(2):e200029
pubmed: 33937821
Sci Data. 2017 Jul 04;4:170077
pubmed: 28675381
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2978-2991
pubmed: 32399621
PLoS One. 2021 Sep 23;16(9):e0257841
pubmed: 34555116
BMC Cancer. 2020 Jan 10;20(1):29
pubmed: 31924170
Radiographics. 2021 Oct;41(6):1717-1732
pubmed: 34597235
Syst Rev. 2020 Mar 9;9(1):53
pubmed: 32164791
Head Neck. 2020 Nov;42(11):3295-3306
pubmed: 32737951
J Comput Assist Tomogr. 2018 Mar/Apr;42(2):299-305
pubmed: 29189396
AJNR Am J Neuroradiol. 2018 Oct;39(10):1878-1883
pubmed: 30213805
AJNR Am J Neuroradiol. 2013 Oct;34(10):2005-9
pubmed: 23660291
Eur Arch Otorhinolaryngol. 2014 May;271(5):1219-25
pubmed: 23880924
Eur J Radiol. 2006 Apr;58(1):113-8
pubmed: 16337355
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Int J Cancer. 2007 Oct 15;121(8):1813-20
pubmed: 17546592
Radiology. 2017 Dec;285(3):713-718
pubmed: 29155639
Br J Radiol. 2018 Jun;91(1086):20170498
pubmed: 29451412
PLoS One. 2015 Jan 23;10(1):e0115451
pubmed: 25616103
Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):921-928
pubmed: 28807534
Cancer Treat Rev. 2014 Mar;40(2):215-9
pubmed: 24080155
Front Oncol. 2018 Aug 17;8:294
pubmed: 30175071
Neuroradiology. 2021 Aug;63(8):1293-1304
pubmed: 33649882
Eur J Radiol. 2020 May;126:108936
pubmed: 32171912
Sci Rep. 2020 Mar 11;10(1):4542
pubmed: 32161279
B-ENT. 2015;11(2):81-7
pubmed: 26563006
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
Eur J Radiol. 2021 Jul;140:109744
pubmed: 33962253
AJR Am J Roentgenol. 2013 Jan;200(1):35-43
pubmed: 23255739
Clin Transl Radiat Oncol. 2017 Nov 06;7:49-54
pubmed: 29594229
Eur Radiol. 2020 Dec;30(12):6858-6866
pubmed: 32591885
Sci Rep. 2016 Mar 24;6:23428
pubmed: 27009765
Sci Rep. 2020 Oct 16;10(1):17525
pubmed: 33067484
Cancers (Basel). 2021 Feb 13;13(4):
pubmed: 33668646
Eur Radiol. 2021 Mar;31(3):1526-1535
pubmed: 32876837
Radiol Med. 2019 Sep;124(9):804-811
pubmed: 30911988
BMJ. 1997 Feb 15;314(7079):498-502
pubmed: 9056804
Oral Oncol. 2021 May;116:105239
pubmed: 33640578
Med Phys. 2020 Feb;47(2):563-575
pubmed: 31853980
AJNR Am J Neuroradiol. 2020 Oct;41(10):1897-1904
pubmed: 32943420
Radiographics. 2017 Sep-Oct;37(5):1483-1503
pubmed: 28898189
J Comput Assist Tomogr. 2013 May-Jun;37(3):343-5
pubmed: 23674003
Cancers (Basel). 2021 May 08;13(9):
pubmed: 34066857
AJNR Am J Neuroradiol. 2015 Jul;36(7):1343-8
pubmed: 25836725
Head Neck. 2021 Feb;43(2):485-495
pubmed: 33029923
Cancer Imaging. 2016 Aug 19;16(1):23
pubmed: 27542718
Clin Cancer Res. 2011 Oct 1;17(19):6262-71
pubmed: 21969383
Diagnostics (Basel). 2021 Jun 30;11(7):
pubmed: 34209197
Eur Radiol. 2021 Jun;31(6):3786-3796
pubmed: 33666696
Laryngoscope. 2021 Mar;131(3):E851-E856
pubmed: 33070337
Eur J Radiol. 2020 Aug;129:109095
pubmed: 32531722
J Comput Assist Tomogr. 2016 Jan-Feb;40(1):43-7
pubmed: 26466116
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929